ED Diabetes Screening and Outpatient Care - Aim 3
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Telehealth Bridge Visits, Standard of Care.
- Who it may be relevant to
- Registry conditions: Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus. Basic parameters: 20 years — 70 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Identifying Risk Factors for Poor Glycemic Control Among Emergency Department Patients and Improving Linkage to Outpatient Care
Overview
This goal of this NIH funded R01 study is to identify risk factors for not being able to follow-up for a new diagnosis of diabetes in the emergency department and improve linkage of these newly diagnosed patients to appropriate outpatient care. Its three aims will be accomplished through 1) a retrospective chart review of emergency department (ED) patients screened for diabetes, 2) a series of prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care, and 3) a simple randomized controlled trial to test the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Interventions
- Other Telehealth Bridge Visits
Patients will be scheduled for a telemedicine visit staffed by a family or internal medicine trained physician who will assess their understanding and answer any questions about the new diagnosis of diabetes, start initial conversations about how to improve their habits around diet and exercise, and discuss medication options for diabetes and, if appropriate, initiate treatment. At the end of the telemedicine visit, providers will attempt to address any difficulties that patients are experiencin - Other Standard of Care
Standard of care currently includes calls from the site's follow-up center to see if patients received their HbA1c result, understood what their result meant, had any problems accessing medications prescribed or any difficulty scheduling an outpatient follow-up visit.
Primary outcome measures
- Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit [Time frame: Up to Month 6 Post-Diagnosis]
Secondary outcome measures (3)
- Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 6 Months of Diagnosis [Time frame: Up to Month 6 Post-Diagnosis]
- Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 12 Months of Diagnosis [Time frame: Up to Month 12 Post-Diagnosis]
- Percent of Patients who Start on Diabetes Medications within 6 Months of Diagnosis [Time frame: Up to Month 6 Post-Diagnosis]
Eligibility criteria
Inclusion criteria
- Emergency patient receiving lab tests with an initial HbA1c test result of ≥ 6.5%
- Residential address in New York City or Long Island
- Primary language is English or Spanish
- Able to provide informed consent
Exclusion criteria
- No prior history of diabetes
- No medical condition that would result in a spurious HbA1c test (e.g., sickle cell, recent blood loss)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Health services research
Study locations
United States · 1 center
- NYU Langone Health — New York
Identifiers
NCT: NCT05899023 · 23-00571 · 5R01DK134668